Miami, Florida
United States
114
2020-04-30
109
2021-03-02
These are the the leading inventors for applications assigned to CuRNA, Inc.:
CuRNA, Inc. based in Miami, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#2 | 2020-01-30 ✅ Patent 10,876,117 granted on 2020-12-29Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#3 | 2019-10-10 ✅ Patent 11,697,814 granted on 2023-07-11Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#4 | 2019-10-10 ✅ Patent 11,339,394 granted on 2022-05-24Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
#5 | 2019-01-24 ✅ Patent 11,390,868 granted on 2022-07-19Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#6 | 2018-10-25 ✅ Patent 10,450,567 granted on 2019-10-22Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#7 | 2018-08-16 ✅ Patent 10,253,320 granted on 2019-04-09Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#8 | 2018-07-26 ✅ Patent 10,487,327 granted on 2019-11-26Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#9 | 2018-07-19 ✅ Patent 10,316,317 granted on 2019-06-11Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)
#10 | 2018-05-17 ✅ Patent 10,435,690 granted on 2019-10-08Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
#11 | 2018-03-08 ✅ Patent 10,280,421 granted on 2019-05-07Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#12 | 2018-02-22 ✅ Patent 10,465,192 granted on 2019-11-05Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
#13 | 2018-02-08 ✅ Patent 10,053,691 granted on 2018-08-21Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#14 | 2018-01-11 ✅ Patent 10,358,645 granted on 2019-07-23Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#15 | 2018-01-04 ✅ Patent 10,793,857 granted on 2020-10-06Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
#16 | 2017-12-14 ✅ Patent 10,337,013 granted on 2019-07-02Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#17 | 2017-12-14 ✅ Patent 10,337,011 granted on 2019-07-02Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21
#18 | 2017-11-16 ✅ Patent 10,100,315 granted on 2018-10-16Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4
#19 | 2017-07-27 ✅ Patent 10,214,745 granted on 2019-02-26Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#20 | 2017-06-01 ✅ Patent 9,970,008 granted on 2018-05-15Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#21 | 2017-05-25 ✅ Patent 9,902,959 granted on 2018-02-27Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN
#22 | 2017-05-25 ✅ Patent 10,995,334 granted on 2021-05-04Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#23 | 2017-03-16 ✅ Patent 10,370,657 granted on 2019-08-06Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
#24 | 2016-11-24 ✅ Patent 9,920,322 granted on 2018-03-20Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#25 | 2016-10-06 ✅ Patent 9,902,995 granted on 2018-02-27Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1
#26 | 2016-09-29 ✅ Patent 9,902,958 granted on 2018-02-27Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
#27 | 2016-09-22 ✅ Patent 9,920,369 granted on 2018-03-20Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3
#28 | 2016-06-16 ✅ Patent 9,909,126 granted on 2018-03-06Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)
#29 | 2016-05-19 ✅ Patent 10,519,448 granted on 2019-12-31Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#30 | 2016-05-12 ✅ Patent 9,873,873 granted on 2018-01-23Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
#31 | 2016-03-31 ✅ Patent 9,834,769 granted on 2017-12-05Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
#32 | 2016-02-18 ✅ Patent 10,696,966 granted on 2020-06-30Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
#33 | 2016-01-28 ✅ Patent 9,957,503 granted on 2018-05-01Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT
#34 | 2016-01-28 ✅ Patent 10,604,755 granted on 2020-03-31Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
#35 | 2016-01-14 ✅ Patent 9,611,477 granted on 2017-04-04Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP
#36 | 2016-01-07 ✅ Patent 9,879,264 granted on 2018-01-30Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
#37 | 2015-11-26 ✅ Patent 9,512,427 granted on 2016-12-06Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
#38 | 2015-10-22 ✅ Patent 9,914,923 granted on 2018-03-13Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#39 | 2015-10-08 ✅ Patent 11,408,004 granted on 2022-08-09Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
#40 | 2015-09-17 ✅ Patent 10,221,413 granted on 2019-03-05Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
#41 | 2015-08-20 ✅ Patent 9,677,074 granted on 2017-06-13Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3)
#42 | 2015-08-13 ✅ Patent 9,745,580 granted on 2017-08-29Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21
#43 | 2015-08-13 ✅ Patent 9,290,766 granted on 2016-03-22Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)
#44 | 2015-07-16 ✅ Patent 9,528,110 granted on 2016-12-27Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP
#45 | 2015-06-18 ✅ Patent 9,809,816 granted on 2017-11-07Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#46 | 2015-06-11 ✅ Patent 10,358,646 granted on 2019-07-23Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#47 | 2015-06-04 ✅ Patent 9,745,584 granted on 2017-08-29Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4
#48 | 2015-06-04 ✅ Patent 10,174,324 granted on 2019-01-08Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
#49 | 2015-06-04 ✅ Patent 9,382,543 granted on 2016-07-05Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#50 | 2015-06-04 ✅ Patent 9,382,538 granted on 2016-07-05Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3
#51 | 2015-06-04 ✅ Patent 10,113,166 granted on 2018-10-30Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#52 | 2015-05-21 ✅ Patent 9,410,155 granted on 2016-08-09Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#53 | 2015-05-14 ✅ Patent 9,394,542 granted on 2016-07-19Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
#54 | 2015-05-14 ✅ Patent 9,745,582 granted on 2017-08-29Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#55 | 2015-05-07 ✅ Patent 9,732,339 granted on 2017-08-15Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
#56 | 2015-04-30 ✅ Patent 9,834,767 granted on 2017-12-05Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#57 | 2015-04-16 ✅ Patent 9,714,423 granted on 2017-07-25Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1
#58 | 2015-04-02 ✅ Patent 9,879,256 granted on 2018-01-30Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF
#59 | 2015-04-02 ✅ Patent 9,533,004 granted on 2017-01-03Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
#60 | 2015-03-26 ✅ Patent 9,765,336 granted on 2017-09-19Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#61 | 2015-03-19 ✅ Patent 9,663,785 granted on 2017-05-30Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
#62 | 2015-03-19 ✅ Patent 9,725,717 granted on 2017-08-08Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3
#63 | 2015-03-12 ✅ Patent 10,036,014 granted on 2018-07-31Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#64 | 2015-02-26 ✅ Patent 9,267,136 granted on 2016-02-23Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
#65 | 2015-02-05 ✅ Patent 9,624,493 granted on 2017-04-18Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#66 | 2014-12-18 ✅ Patent 9,771,593 granted on 2017-09-26Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
#67 | 2014-10-16 ✅ Patent 10,583,128 granted on 2020-03-10Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules
#68 | 2014-09-25 ✅ Patent 9,133,456 granted on 2015-09-15Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
#69 | 2014-09-25 ✅ Patent 9,725,756 granted on 2017-08-08Treatment of ‘C terminus of HSP7O-interacting protein’ (CHIP) related diseases by inhibition of natural antisense transcript to CHIP
#70 | 2014-07-03 ✅ Patent 9,593,330 granted on 2017-03-14Treatment of frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXN
#71 | 2014-06-05 ✅ Patent 9,163,285 granted on 2015-10-20Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP
#72 | 2013-10-03 ✅ Patent 8,987,225 granted on 2015-03-24Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#73 | 2013-09-26 ✅ Patent 9,222,088 granted on 2015-12-29Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
#74 | 2013-09-19 ✅ Patent 10,000,752 granted on 2018-06-19Antagonat compositions and methods of use
#75 | 2013-09-19 ✅ Patent 8,993,533 granted on 2015-03-31Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4
#76 | 2013-08-15TREATMENT OF INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1 (IFRD1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IFRD1
#77 | 2013-07-18TREATMENT OF HEPATOCYTE GROWTH FACTOR (HGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO HGF
#78 | 2013-06-06 ✅ Patent 8,980,860 granted on 2015-03-17Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
#79 | 2013-05-30TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#80 | 2013-05-09 ✅ Patent 9,173,895 granted on 2015-11-03Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
#81 | 2013-04-18 ✅ Patent 9,771,579 granted on 2017-09-26Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
#82 | 2013-04-04 ✅ Patent 8,895,528 granted on 2014-11-25Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#83 | 2013-03-21 ✅ Patent 8,980,858 granted on 2015-03-17Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA
#84 | 2013-03-21 ✅ Patent 9,089,588 granted on 2015-07-28Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)
#85 | 2013-03-14 ✅ Patent 8,980,857 granted on 2015-03-17Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4
#86 | 2013-02-07 ✅ Patent 9,044,494 granted on 2015-06-02Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21
#87 | 2013-02-07 ✅ Patent 8,980,856 granted on 2015-03-17Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3
#88 | 2012-12-27 ✅ Patent 8,940,708 granted on 2015-01-27Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF
#89 | 2012-12-27 ✅ Patent 9,068,183 granted on 2015-06-30Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
#90 | 2012-12-20 ✅ Patent 8,912,157 granted on 2014-12-16Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
#91 | 2012-12-06 ✅ Patent 8,962,586 granted on 2015-02-24Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#92 | 2012-11-22 ✅ Patent 8,946,182 granted on 2015-02-03Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#93 | 2012-11-22 ✅ Patent 8,946,181 granted on 2015-02-03Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#94 | 2012-11-22 ✅ Patent 8,962,585 granted on 2015-02-24Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
#95 | 2012-11-22TREATMENT OF FILAGGRIN (FLG) RELATED DISEASES BY MODULATION OF FLG EXPRESSION AND ACTIVITY
#96 | 2012-11-15TREATMENT OF INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 AND TRANSCRIPTION FACTOR E3 (TFE3)
#97 | 2012-11-01 ✅ Patent 9,200,277 granted on 2015-12-01Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
#98 | 2012-10-18 ✅ Patent 8,921,334 granted on 2014-12-30Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
#99 | 2012-06-14 ✅ Patent 9,234,199 granted on 2016-01-12Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
#100 | 2012-06-07 ✅ Patent 8,921,330 granted on 2014-12-30Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
Also check out CuRNA, Inc.'s (Miami, United States) applicant profile with 70 patent applications submitted.
8403 ⎘